Core medical trainee, Crosshouse Hospital, Kilmarnock, UK.
Respir Med. 2010 Dec;104(12):1767-74. doi: 10.1016/j.rmed.2010.08.005. Epub 2010 Sep 15.
Lung cancer remains the most common cause of cancer-related mortality in Scotland, accounting for 28.9% of all cancer deaths in 2007. (1) Current guidelines recommend assessment of patient fitness and operability by a multi-disciplinary team when selecting management options. (2-6) Two of the most important prognostic markers are the stage of disease and ECOG performance status. The most commonly used cancer staging system is the tumour, node, metastasis (TNM) staging system, which is maintained by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC). In 1998, the International Association for the Study of Lung Cancer (IASLC) established The Lung Cancer Staging Project, collecting data on over 100,000 patients diagnosed with lung cancer between 1990-2000 worldwide, in order to revise the 6th edition TNM staging system for non-small cell lung cancer (NSCLC).(7) The 7th edition was published in late 2009. This review of staging in NSCLC, includes a summary of the different staging techniques currently available and the 7th edition TNM staging system for NSCLC.(8).
在苏格兰，肺癌仍然是癌症相关死亡的最常见原因，占 2007 年所有癌症死亡人数的 28.9%。(1)目前的指南建议在选择管理方案时，由多学科团队评估患者的健康状况和可操作性。(2-6)两个最重要的预后标志物是疾病分期和 ECOG 表现状态。最常用的癌症分期系统是肿瘤、淋巴结、转移 (TNM) 分期系统，由美国癌症联合委员会 (AJCC) 和国际癌症联合会 (UICC) 维护。1998 年，国际肺癌研究协会 (IASLC) 成立了肺癌分期项目，收集了 1990-2000 年间全球超过 100,000 例肺癌患者的数据，以修订第六版非小细胞肺癌 (NSCLC) 的 TNM 分期系统。(7)第七版于 2009 年末出版。本综述介绍了 NSCLC 的分期，包括目前可用的不同分期技术和第七版 NSCLC 的 TNM 分期系统。(8)
